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Background/aim: This study aimed to investigate the effectiveness of a supervised group exercise therapy based on the biopsychosocial
model introduced simultaneously with antitumor necrosis factor (TNF) therapy in anti-TNF-naive patients with active ankylosing
spondylitis (AS).
Materials and methods: Forty-eight patients were divided into two groups: the control group (CG; n = 36) received only anti-TNF
therapy, and the study group (SG; n = 12) received the supervised exercise therapy based on the biopsychosocial model in addition
to anti-TNF therapy. The measurements of disease activity and functionality were evaluated by The Bath AS Disease Activity Index
(BASDAI) and The Bath AS Functional Index (BASFI) respectively. Other outcome measures evaluated biopsychosocial status,
emotional state, spinal mobility, pain, fatigue, sleep, and quality of life. All measurements were applied to both groups at baseline and
repeated 12 weeks later.
Results: BASDAI and BASFI analyses revealed significant differences between groups in favor of the SG (p < 0.05). At the end of the
12 weeks, the results showed that there were additional improvements in all outcome measurement parameters in the SG compared to
the CG.
Conclusion: The supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with anti-TNF
therapy is more effective than only anti-TNF therapy in anti-TNF-naive patients with active AS.
Key words: Ankylosing spondylitis, biologic therapy, exercise, psychosocial aspects, TNF-alpha

1. Introduction
Ankylosing spondylitis (AS) is a chronic, inflammatory,
common rheumatic disease of unknown etiology, mainly
affecting the sacroiliac joints and the axial skeleton. It
can also affect peripheral joints, tendons, ligaments, and
extraarticular organs [1,2]. The course of the disease may
vary as symptoms are observed in a wide range, from mild
to severe [3]. The main complaints of the patients with AS
are pain, joint stiffness, fatigue, and functional limitations,
which can significantly affect the quality of life and job
productivity [4,5]. Patients with AS often experience
fatigue, sleep problems, depression, and anxiety, which are
the main symptoms that negatively affect daily life [6–9].
Moreover, AS is compatible with the central sensitization
mechanism as the nature of chronic pain is an aspect of
the biopsychosocial model [10]. All these conditions

reveal the importance of biopsychosocial approaches in
the treatment of patients with AS [11].
The Assessment in SpondyloArthritis international
Society (ASAS) and the European League Against
Rheumatism (EULAR) have reported that optimal
management in AS is provided by a combination of
pharmacological and nonpharmacological treatments.
Regular exercise and patient education play a key role in
the nonpharmacological treatment of patients with AS
[12,13]. Although the positive effects of exercise have
been shown by comprehensive studies, the superiority of
different types of exercise regimens is still unclear [13,14].
However, the EULAR recommended that pain should
be considered from a biopsychosocial perspective, and
its management should be planned in accordance with a
biopsychosocial approach [15].
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Antitumor necrosis factor-alpha (TNFα) therapy,
which is often used in patients who do not benefit from
routine pharmacological treatment, creates a remarkable
difference especially in the treatment of axial involvement,
peripheral arthritis, and enthesitis. Some studies have also
shown positive effects on quality of life, spinal mobility,
depression, and C-Reactive Protein levels [9, 12,16]. Due
to the extraordinary advances, this therapy has created in
AS management, investigation of the additional beneficial
effects of exercise programs alongside anti-TNF therapy
has become significant [17]. In this direction, some studies
have shown these additional positive effects. However, in
almost all of these studies, patients who participated in
exercise therapy were anti-TNF-experienced [18]. There is
no study in the literature investigating these effects based
on the biopsychosocial model in patients with active AS
who have not used anti-TNF agents before. Therefore, our
study aimed to investigate the effectiveness of a supervised
group exercise therapy based on the biopsychosocial
model introduced simultaneously with anti-TNF therapy,
primarily on disease activity and functionality, in antiTNF-naive patients with active AS.
2. Materials and Methods
2.1. Subjects
Seventy-eight patients diagnosed with AS according to the
Modified New York Criteria and aged 18-65 years were
registered in the study. Subjects were eligible to participate
in the study if they were anti-TNF-naive patients with
active AS and they were going to begin this treatment.
Exclusion criteria included the presence of severe systemic
diseases, pregnancy, exercising regularly, participation
in rehabilitation treatment in the previous three months,
having mental disorders, another chronic inflammatory
disease history, and variations in their biological therapy
regimens during the study.
Our center provides service to patients with rheumatic
diseases from all over Turkey. Randomization could not be
performed entirely in this study, as patients coming from
outside the city would not be able to participate in exercise
sessions. In this way, the patients were divided into two
groups according to whether they lived in the city where
the study was performed. Thus, out-of-city patients (n =
62) were invited to the control group (CG), and patients
living in the same city as our center (n = 16) were invited
to the study group (SG). The study was approved by the
Ethical Committee of Hacettepe University (KA-17022)
and conducted following the principles of the Declaration
of Helsinki. Written consent was obtained from all the
participants.
2.1.1. Study group (SG)
Anti-TNF-naive patients in the SG were included in
the supervised group exercise therapy based on the
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biopsychosocial model (named as “Bilişsel Egzersiz Terapi
Yaklaşımı” (BETY) in original; “the Cognitive Exercise
Therapy Approach” in English). The BETY has been used
in patients with AS [19] and it is applied in six stages:
(1) meeting with the patient; (2) problem analysis; (3)
pain management strategies; (4) change and recovery
agreement; (5) core stabilization training; and (6) dance
therapy-authentic movement (Appendix A). The patients
in the SG participated in group exercise sessions for 12
weeks (3 times a week) following the initiation of the antiTNF therapy. The weekly group exercise sessions were
supervised by a physical therapist and each session took 1
h (Appendix B).
2.1.2. Control group (CG)
The control group receiving only the anti-TNF therapy
was reevaluated at the end of 12 weeks.
2.2. Measurements
Sociodemographic characteristics including age, sex, body
mass index, disease features (duration of symptoms, time
since diagnosis), and smoking status were recorded at
baseline in both groups. In addition, other measurements
were administered in both groups at baseline and 12 weeks
later. The measurements were as follows:
A. Bath AS Functional Index (BASFI): The BASFI was
used to determine the functional levels of the patients. This
index has 10 questions evaluating the daily living activities.
The total BASFI score ranges from 0 to 10 (higher scores
reflect a greater impairment) [20].
B. Bath AS Disease Activity Index (BASDAI): The
BASDAI was used to determine the disease activity levels
of the patients. This index consists of 6 items related to
5 symptoms that occurred during the previous week:
fatigue, spinal pain, joint pain/swelling, tenderness, and
morning stiffness. The total BASDAI score ranges from 0
to 10 (higher scores reflect greater disease activity). A total
score of ≥ 4 indicates that the disease is active [21].
C. Health Assessment Questionnaire (HAQ): The
HAQ was used to assess the health and disability status.
This questionnaire consists of 20 items, and the total score
is between 0 and 3 (higher scores reflect a higher disability)
[22].
D. BETY-Biopsychosocial Questionnaire (BETYBQ): The BETY-BQ was used to assess the biopsychosocial
status. It was developed via feedback received from
rheumatic patients who received therapy involving a
biopsychosocial model (named the BETY) [23]. The
validity, reliability, and responsiveness study of the BETYBQ was conducted in AS patients. This questionnaire
consists of 30 items, and the total score is between 0 and
120. A higher score refers to a poor biopsychosocial status
[24].
E. Hospital Anxiety and Depression Scale (HADS):
The HADS was used to determine the depression and
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anxiety levels of the patients [25]. This scale consists of
14 items. Odd-numbered items evaluate anxiety, and
even-numbered items evaluate depression. As a result,
two separate total scores between 0 and 21 are obtained
for anxiety and depression. A higher score refers to poor
depression and anxiety levels. The cut-off values of the scale
were determined as 10 for anxiety and 7 for depression.
F. Tragus-to-wall distance, lateral lumbar flexion,
and cervical rotation: These three measurements were
performed bilaterally to evaluate spinal mobility, and
the mean of both sides were recorded. Tragus-to-wall
distance and lateral lumbar flexion were measured with a
tape measure, and the value was recorded in centimeters
(cm). The cervical rotation was measured by a universal
goniometer, and the value was recorded in degrees.
G. Visual Analogue Scale (VAS): Patients were asked
to indicate the level of pain on a 10-cm VAS at rest and in
activity. In addition, fatigue levels were measured in the
same way (A score of 0 indicates no pain/fatigue and a
score of 10 indicates very severe pain/fatigue).
H. Pittsburgh Sleep Quality Index (PSQI): The PSQI
was used to assess subjective sleep quality [26]. This index
consists of 24 items and 7 subscales and the total score is
between 0 and 21. A high score is related to poor sleep
quality. If the total score is 5 or below, sleep quality is
interpreted as ‘good’ and if it is above 5, sleep quality is
interpreted as ‘bad’.
I. Short Form-36 (SF-36): The SF-36 was used to assess
the quality of life [27]. It consists of eight subdimensions
and each subdimension is scored separately between 0 and
100. Higher scores indicate better health.
2.3. Statistical analysis
Data analyses were performed using the IBM SPSS
Statistics 23.0 software package. The normality for
continuous variables was checked using the KolmogorovSmirnov/Shapiro-Wilk test and histogram graphics.
Descriptive statistics are presented as mean values and
standard deviation or median and minimum-maximum
values for quantitative variables according to normal
distribution status, and as number and percentage (%) for
qualitative variables. For both groups, the independentsamples t-test was used in parametric data, and the
Mann-Whitney U test was used in nonparametric data to
determine whether there was a difference between baseline
conditions. Categorical variables were analyzed by the
Fisher’s exact test. A two-way repeated-measures ANOVA
was used to examine the main effects and the interaction
between groups and times in case of normal distribution.
The Bonferroni test was selected for multiple comparisons.
Besides, the independent-samples t-test was used to analyze
the difference in the change of parametric data between
the two groups after the intervention. The Mann-Whitney
U test was used to analyze differences between groups, and

the Wilcoxon test was used to analyze differences within
groups in case of nonnormal distribution. A p < 0.05 was
accepted as statistically significant.
3. Results
3.1. Initial evaluation
After some of the patients withdrew from the study for
various reasons, a total of 48 patients completed the 12week therapy (Figure). The initial values of the main
demographic characteristics and all evaluations of the
patients in the SG and CG were similar (Tables 1, 2, and
3). All patients were initially in the active disease period
(BASDAI ≥ 4). Considering the cut-off values of the HADS
and PSQI, patients in both groups initially showed anxiety
and depression and were observed to have low sleep
quality.
3.2. Effects of intervention
Improvements in BASFI, BASDAI, HAQ, BETY-BQ, and
HADS scores were observed in both groups (p1). The
decrease in these scores over time was significant (p2)
in both groups; however, there was a difference between
groups in terms of the amount of this decrease (p3). This
difference was stemmed from group-time interaction.
While there were no differences between the groups in
the initial evaluations of BASFI, BASDAI, HAQ, BETYBQ, and HADS measurements, there were significant
differences in the postintervention evaluations (p4). When
the descriptive statistics of these scores were analyzed, it
was seen that these differences were in favor of the SG
(Table 2).
Table 3 summarizes the comparison of baseline and
postintervention scores of tragus-to-wall distance, lateral
lumbar flexion, cervical rotation, pain, fatigue, the PSQI,
and the SF-36 within the groups. While all of these
measurements showed significant improvements in the SG
(p < 0.05); the improvements in the tragus-to-wall distance,
lateral lumbar flexion, pain at rest level, and both social
function and emotional role subdimensions of SF-36 were
not significant in the CG (p > 0.05). When the differences
of these measurements before and after the intervention
were compared between the groups, it was seen that the
improvements in the SG were greater than those in the CG
except for the social function subdimension score of the
SF-36 (Table 4).
4. Discussion
Our outcome measurement parameters were related to
functionality and daily living activities, disease activity,
biopsychosocial status, emotional status, spinal mobility,
pain, fatigue, sleep, and quality of life. Although both
groups presented positive results compared to baseline
measurements, a combination of supervised group exercise
therapy based on the biopsychosocial model and anti-
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78 patients who met the inclusion criteria

Initial Evaluation

Study Group
(n=16)

Control Group
(n=62)

Anti-TNF therapy + BETY
program

Anti-TNF therapy

4 patients withdrew:
*Difficulty getting
permission from work
*Distance between home and
hospital
*Medication change
*Lack of time

12 weeks treatment

26 patients withdrew:
*Unwilling to participate
*Medication change
*Lack of time
*Starting an exercise program
* The patient cannot be reached
*Patient's decision to continue drug
treatment in the city where he/she lives

Final Evaluation

Study Group
(n=12)

Control Group
(n=36)

Figure. Patients’ flow diagram.

TNF therapy demonstrated additional improvements in
all parameters compared to the control group. Moreover,
these improvements in the SG occurred earlier in the
same time frame. At the end of 12 weeks, all parameters
improved in the SG, while the CG showed no changes in
tragus-to-wall distance, lateral lumbar flexion, pain level
at rest, and social function and emotional role limitation,
which are subdimensions of quality of life.
The BETY was introduced to the literature for the
first time in patients with AS who received routine
pharmacological treatment. Kisacik et al. have investigated
the antiinflammatory effects of the BETY in patients with
AS who had never received anti-TNF therapy. At the
end of their three-month follow-up study, they reported
that the BETY yielded positive effects on symptoms
and antiinflammatory results in patients with AS [19].
The BETY was chosen as the biopsychosocial approach
in our study since its synergistic effects with routine
treatment have been shown before. Biological agents are
highly recommended in patients who do not respond
to nonsteroidal antiinflammatory drugs or for whom
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these drugs are contraindicated [28,29]. The guidelines
recommend anti-TNF agents as the first line of biologic
agents, mainly because of a more widespread clinical
experience and superior investigations data with these
agents [29]. Therefore, to increase the homogeneity of the
included patients, only patients who received anti-TNF
therapy as a biologic agent were selected in our study.
Although there is no consensus on optimal exercise
training in patients with AS, regular exercise has been
strongly recommended by experts. Given the improvements
in AS treatment due to the remarkable effects of anti-TNF
agents, it is recommended to investigate the additional
beneficial effects of exercise therapy [17]. Many studies in
the literature have examined the effectiveness of anti-TNF
therapy alone. Recently, the possible benefits of anti-TNF
therapy combined with exercises have been investigated.
Liang et al. showed that combinations of anti-TNF therapy
and exercise in anti-TNF-experienced patients caused a
significant decrease in BASDAI scores compared to antiTNF alone in a systematic review [30]. Similar results
were obtained in our study. In the SG, BASDAI scores
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Table 1. Main demographic and clinical features of AS patients in the study and control groups.
SG
(n = 12)

CG
(n = 36)

Characteristic

x̄ ± SD

x̄ ± SD

Age (year)

38.75 ± 9.52

39.31 ± 9.89

0.866

Height (cm)

163.17 ± 5.73

163.60 ± 10.33

0.891

Weight (kg)

70.42 ± 12.16

71.4 ± 16.52

0.851

BMI (kg/m )

26.41 ± 4.10

26.51 ± 4.82

0.948

Median (min-max)

Median (min-max)

Mann-Whitney U test p

Disease duration (years)

2.00 (0–21)

2.00 (0–30)

0.862

Symptom duration (years)

11.00 (2–25)

8.00 (0–35)

0.200

Delay time for diagnosis (years)
Sex

5.50 (1–15)

5.00 (0–15)

0.298

Female (%)

10 (83.3)

21 (58.3)

Male (%)

2 (16.7)

15 (41.7)

Smoking

n (%)

Yes (%)

2 (16.7)

14 (38.9)

No (%)

10 (83.3)

22 (61.1)

2

n (%)

Independent samples t-test p

Fisher’s Exact Test
0.169

0.289

BMI: Body mass index x̄ : Mean, SD: Standard deviation

were declined more than those of the CG. Spadaro et al.
included 27 patients stabilized with anti-TNF treatment
for at least 12 weeks in their study and demonstrated the
effectiveness of home-based occupational therapy, which
included a comprehensive patient training program and
exercise [31]. In particular, according to the BASDAI,
it is noteworthy that the control group, which had no
active disease at the beginning, indicated the value of the
active disease at the end of 16 weeks. This may suggest
that nonpharmacological treatments are needed due to
the chronic nature of the disease, even if the anti-TNF
agent is used in patients with AS. Also, in their study, the
range of motion exercise of the spine was recommended
as a home program, but the exercises were not detailed
in terms of frequency, intensity, and duration. In our
study, supervised group exercises were an important
part of the treatment. Some patient-specific exercises
were given as a home program, and pain management
strategies were encouraged in case pain occurs. Masiero
et al. conducted a randomized controlled study including
62 stabilized patients with AS who had been receiving
anti-TNF treatment for at least 9 months. The group, in
which anti-TNF therapy, educational-behavioral patient
training, and exercise therapy were given together, showed
greater improvements in evaluation parameters such as
functionality, disease activity, and spinal mobility. In this
study, it was emphasized that pharmacological treatment
alone could not prevent the need for exercise due to the

additional improvements obtained with combined therapy
[32]. Their study is similar to our study in terms of having
results emphasizing the importance of exercise; however,
in that study, psychosocial dimensions of an exercise
program were not investigated in anti-TNF-naive active
AS patients. In our study, anxiety and depression levels,
sleep problems, and the quality of life of these patients
were also evaluated. In all these measurements, the SG
showed greater improvement than the CG. Yiğit et al.
reported that the home exercise program was effective on
disease activity, functionality, spinal mobility, depression,
fatigue, and quality of life in their study, which included 40
stabilized patients with AS who had been receiving antiTNF treatment for at least 6 months [33]. In other similar
studies, the positive effects of a combination of a home
exercise program, incentive spirometry exercises, and spa
therapy with anti-TNF treatment have been demonstrated
[34–36]. All these studies investigating exercise programs
in patients with AS receiving anti-TNF therapy included
patients who had received anti-TNF treatment for at least
three months.
There are very few studies involving simultaneous
effects of exercise along with anti-TNF therapy. Coksevim
et al. examined the effects of global postural reeducation
(GPR) exercises performed simultaneously with anti-TNF
therapy in their study involving 60 patients with active
AS. After the exercises were taught to the patients by the
physiotherapist, the patients were asked to perform these
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Table 2. Baseline and postintervention scores of the BASFI, BASDAI, HAQ, BETY-BQ, and HADS within
and between the groups.
Initial evaluation

Final evaluation

BASFI (0–10)

x̄ ± SD

x̄ SD

p1

p2

p3

SG

5.68 ± 1.44

1.52 1.08

<0.001

CG

5.13 ± 2.43

3.52 ± 2.19

<0.001

<0.001

0.01

p

0.464

0.04

BASDAI (0–10)

x̄ ± SD
1.84 ± 1.07

p1

p2

p3

SG

x̄ ± SD
6.01 ± 1.56

CG

6.12 ± 1.77

4.49 ± 2.13

<0.001

<0.001

<0.001

p4

0.851

0.00*

HAQ (0–3)

x̄ ± SD
0.29 ± 0.29

p1

p2

p3

SG

x̄ ± SD
1.20 ± 0.47

CG

1.17 ± 0.69

0.80 ± 0.60

<0.001

<0.001

0.01

p

0.893

0.007

BETY-BQ (0–120)

x̄ ± SD
20.67 ± 10.14

p1

p2

p3

SG

x̄ ± SD
66.25 ± 20.57

CG

59.33 ± 25.14

44.28 ± 23.23

<0.001

<0.001

<0.001

p4

0.394

0.001*

HADS-A (0–21)

x̄ ± SD
3.33 ± 1.67

p1

p2

p3

SG

x̄ ± SD
12.33 ± 4.73

CG

10.33 ± 5.38

7.72 ± 4.70

<0.001

<0.001

<0.001

p

0.258

0.003

HADS-D (0–21)

x̄ ± SD
2.75 ± 2.26

p1

p2

p3

SG

x̄ ± SD
9.67 ± 3.62

CG

8.89 ± 4.70

5.78 ± 4.70

<0.001

<0.001

0.001

p

0.604

0.038

4

4

4

4

*

<0.001

<0.001

*

<0.001

<0.001

*

<0.001

*

A two-way repeated-measures ANOVA
p1: Comparison of the first and second evaluations within groups (pairwise comparison)
p2: General comparison of change over time
p4: Comparison of first and second evaluations between groups (pairwise comparison)
BASFI: Bath Ankylosing Spondylitis Functional Index; BASDAI: Bath Ankylosing Spondylitis
Disease Activity Index; HAQ: Health Assessment Questionnaire; BETY-BQ: BETY-Biopsychosocial
Questionnaire; HADS: Hospital Anxiety and Depression Scale; x̄ : Mean; SD: Standard Deviation.
*
Significant at p < 0.05.

exercises in the form of a home-based program for at least
30 min per session for 5 days a week for three months.
The anti-TNF treatment combined with GPR exercises
showed greater improvements in pain, function, and
mobility [37]. Our study differs from other studies in the
literature in terms of using a biopsychosocial approach,
which is recommended by the EULAR guidelines
[15]. Anti-TNF-naive patients were selected and a
physiotherapist-supervised group exercise program was
initiated concurrently with medical treatment. Performing
the sessions in the form of supervised group exercises may
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be a factor that increases motivation and socialization. The
BETY, which includes pain management, dance therapyauthentic movement, cognitive restructuring about
disease, and function-oriented core stabilization exercises,
is presented in this study as an effective exercise program
when introduced simultaneously with anti-TNF therapy
in anti-TNF-naive patients with active AS.
4.1. Limitations
There are several limitations of the study such as small
sample size and lack of randomization of the participants. In
our study, the intermalleolar distance and the lumbar flexion

KARACA et al. / Turk J Med Sci
Table 3. Baseline and postintervention scores of tragus-to-wall distance, lateral lumbar flexion, cervical rotation, pain,
fatigue, PSQI, and SF-36 within the groups.

Tragus-to-wall distance (cm)

Initial evaluation

Final evaluation

Wilcoxon test

Median (min-max)

Median (min-max)

p

SG

17.25 (13.0–23.5)

13.2 (10.0–21.0)

0.002*

CG

17.0 (10.0–26.5)

16.5 (7.0–26.0)

0.554

p*
Lateral lumbar flexion (cm)

0.933
SG

8.0 (5.0–15.0)

15.5 (10.0–20.0)

0.002*

CG

8.75 (2.0–21.0)

9.0 (2.0–21.0)

0.897

p

0.633

*

Cervical rotation (°)

SG

53.75 (6.5–62.5)

63.75 (32.5–85.0)

0.002*

CG

45.0 (7.5–65.0)

45.0 (15.0–70.0)

<0.001*

p

0.212

*

Pain-at rest
(VAS, cm) (0–10)

SG

7.0 (3–9)

3.0 (0–4)

0.002*

CG

7.0 (2–10)

4.0 (0–9)

0.221

p

0.818

*

Pain-in the activity
(VAS, cm) (0–10)

SG

6.0 (4–10)

1.5 (0–4)

0.002*

CG

7.0 (1–10)

4.0 (0–9)

0.000*

p*
Fatigue
(VAS, cm) (0–10)

0.916
SG

7.5 (5–10)

3.0 (0–4)

0.002*

CG

8.0 (3–10)

6.0 (1–10)

<0.001*

p*
PSQI (0–21)

0.627
SG

13.0 (7–17)

1.0 (0–6)

0.002*

CG

11.0 (0–17)

10.5 (0–16)

0.028*

p

0.338

*

SF-36 (0-100)
Physical Functioning

SG

38.8 (11.1–83.3)

80.5 (61.1–94.4)

0.002*

CG

27.7 (0.0–88.8)

66.6 (0.0–100)

<0.001*

p*
Role physical

0.981
SG

0.0(0–0)

100 (25.0–100.0)

0.002*

CG

0.0 (0.0–100)

12.5 (0.0–100)

0.004*

p*
Bodily pain

0.078
SG

45.0 (22.5–67.5)

85.0 (67.5–90.0)

0.002*

CG

32.5 (10.0–80.0)

66.2 (22.5–100)

<0.001*

p*
Social functioning

0.160
SG

50.0 (0.0–100)

100 (50.0–100.0)

0.008*

CG

50.0 (0.0–100)

93.75 (0.0–100)

0.066

p*
Mental health

0.990
SG

56.0 (24.0–76.0)

80.0 (44.0–88.0)

0.002*

CG

52.0 (12.0–88.0)

64.0 (24.0–96.0)

<0.001*

p

0.792

*

Role emotional

SG

0.0 (0.0–100)

83.3 (0.0–100)

0.004*

CG

0.0 (0.0-100)

0.0 (0.0-100)

0.269
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Table 4. (Continued).
p*

0.184

Vitality

SG

25.0 (0.0–60.0)

60.0 (35.0–80.0)

0.003*

CG

25.0 (0.0–80.0)

50.0 (10.0–90.0)

<0.001*

p*

0.540

General health
p*

SG

35.0 (25.0–65.0)

60.0 (35.0–85.0)

0.003*

CG

40.0 (5.0–90.5)

45.0 (15.0–90.0)

0.034*

0.449

VAS: Visual Analogue Scale; PSQI: Pittsburgh Sleep Quality Index; SF-36: Short Form-36. p* values for differences in the
baseline data between the SG and the CG using the Mann-Whitney-U test. *Significant at p < 0.05.

Table 4. Postintervention difference scores of tragus-to-wall distance, lateral lumbar flexion, cervical
rotation, pain, fatigue, PSQI, and SF-36 between the groups.
SG (n = 12)

CG (n = 36)

Median (min-max)

Median (min-max)

Tragus-to-wall distance

3.25 (1.5/6.5)

0.5 (–7/7)

<0.001*

Lateral lumbar flexion

–5.75 (–3/–8)

0.0 (–8.5/8.5)

<0.001*

Cervical rotation (°)

–20.0 (–10/–35)

–2.50 (0/–17.50)

<0.001*

Pain-at rest

4.0 (2/7)

1.0 (–4/10)

0.001*

Pain-in activity

5.0 (3/8)

2.0 (–4/10)

0.001*

Fatigue

5.0 (2/8)

2.0 (–3/6)

<0.001*

PSQI (0–21)

10.5 (6/17)

1.0 (–9/9)

<0.001*

Physical functioning

–38.85 (–11.1/–77.8)

–11.15 (27.7/–66.7)

0.002*

Role physical

–100.0 (–25/–100)

0.0 (75/–100)

0.001*

Bodily pain

–35.0 (–10/–55)

–22.5 (12.5/–87.5)

0.042*

Social functioning

–31.25 (0/–100)

0.0 (–100/100)

0.108

Mental health

–22.0 (–8/–56)

–12.0 (28/–76)

0.050

Role emotional

–66.6 (0/–100)

0.0 (–100/100 )

< 0.001*

Vitality

–32.5 (0/–55)

–22.5 (20/–60)

0.050

General health

–20.0 (0/–55)

–10.0 (35/–40)

0.015*

p*

SF-36 (0–100)

VAS: Visual Analogue Scale, PSQI: Pittsburgh Sleep Quality Index, SF-36: Short Form-36. *Significant
at p < 0.05. Mann-Whitney-U test

measurements could not be made due to the lack of a suitable
environment for the control group’s evaluation. Therefore,
the Ankylosing Spondylitis Metrology Index score for
mobility assessment could not be obtained. Considering
the positive effects of anti-TNF agents at 16–24 weeks on
ASAS response, the longer duration of the study might have
resulted in more accurate interpretations. Further studies
with longer follow-up and larger sample sizes are needed.
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4.2. Conclusion
It was concluded that the supervised group exercise
therapy based on the biopsychosocial model introduced
simultaneously with anti-TNF therapy is more effective
than only anti-TNF therapy in anti-TNF-naive patients
with active AS. In addition, this original study provides an
example of a biopsychosocial model suitable for clinical
practice in this patient group.
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Appendix A. Process of the BETY.
Meeting with the patient: The characteristics of the disease are explained. The anxiety and fear of the patient regarding their disease
are minimized.
Problem analysis: The patient is asked about their primary complaint and functional problem regarding their disease. After the
problem is identified, exercises that can solve the patient’s complaints are taught. These also form the patient’s home-based exercise
program.
Pain management strategies: The relationship between pain-muscle spasms and limbic system via central sensitization mechanism;
pain coping skills and problem-solving techniques (activity-rest cycling, pleasant activity planning, pleasant imagery, etc.); positive
thinking and distraction strategies about pain management are presented.
Change and recovery agreement: The patient is asked to restrict the activity in the painful body area and to perform the exercises
when pain occurs during the day. Active participation of the patient in the treatment is encouraged and the patient’s awareness about
the responsibility towards treatment is increased. Change and recovery agreement is made with the patient who agrees to participate
actively.
Core stabilization training: Head and neck, shoulders, chest, lumbopelvic region postures and respiratory control, which are
features of core stabilization, are explained and taught.
Dance therapy-authentic movement: Dance therapy-authentic movement can be applied at the beginning and at the end of
the session. Following the commands given by the physiotherapist accompanied by music, the patients are asked for an instant
movement called “authentic movement”. At this point, it is aimed to distract the patient’s attention from the pain and the related
body area and correct the posture impaired by the muscle spasm.
Appendix B. Process the core stabilization exercises.
0–6. weeks
Warm-up phase  

Main exercise training phase
(0-3. weeks)

•Mini squat
•Roll down
•PNF patterns-upper extremity
•Cleopatra  
•Chest stretch
•Swinging  
•Dumb waiter

•Hundreds 1-2
•One leg stretch
•Double leg stretch
•Shoulder bridge
•Swan dive
•Swimming
•Clam
•Hip twist
•Sidekick
•One leg kick 1
•Roll down
6–12. weeks (resistive exercise with exercise band)
Warm-up phase
·Mini squat
·Roll down
·PNF patterns-upper extremity
·Cleopatra
·Chest stretch
·Swinging
·Dumb waiter

Main exercise training phase
(0-6. weeks)
·Hundreds 3
·Shoulder bridge 1
·One leg stretch
·Double leg stretch
·Swan dive
·Swimming
·Clam
·Hip twist
·Sidekick 2
·Arm openings 1-2

Main exercise training phase
(6–9. weeks)

Main exercise training phase
(9–12. weeks)

·Abdominal preparation
·Shoulder bridge 2
·Sidekick press
·One leg stretch 2
·Parallel (double leg)
·Parallel (single leg)
·Point & Flex
·Diamond press
·Breaststroke

·Hundreds
·Side circles
· Shoulder bridge 2
·One leg stretch 3
·Heels together toes apart
·External rotation
·Diamond press with arm openings
·Roll up with obliques

Cool-down phase
·The saw
·Mermaid
·Chest stretch
·Swinging

Cool-down phase
·Mermaid
·Spine twist
·Side bend
·Chest stretch
·Crock screw

Note: The exercises are generally progressed in this way, but differences occurred between patients due to differences in their tolerance levels
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